DB Ashbourne
- Date of Transaction: Sep 2015
- Acquirer: Ethypharm
- Service: M&A
- Sector: N/A
I am very pleased to have found such a complementary match in Ethypharm, a highly successful manufacturer of sustained release drugs with an established history of drug development.
Gordon advised the shareholders of DB Ashbourne, a provider of off-patent branded pharmaceuticals for the UK market, on their sale to Ethypharm S.A, a French company with an international presence which develops innovative pharmaceutical products.
Welcome to Alpha Helix
We are pleased to announce that on 12th March of this year, Gordon Hamilton led the MBO of Nexus Corporate Finance (NCF), therefore we have re-branded as Alpha Helix Corporate Finance (AHCF).
The team will remain unchanged and will continue to provide independent advice to exciting and fast-growing UK SMEs in the Healthcare sector.